Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Private Sector | 1 | 2021 | 262 | 0.73 | Why? |
| Mosquito Control | 1 | 2019 | 237 | 0.66 | Why? |
| Mosquito Vectors | 1 | 2019 | 351 | 0.62 | Why? |
| Aedes | 1 | 2019 | 380 | 0.60 | Why? |
| Triazoles | 1 | 2018 | 440 | 0.54 | Why? |
| Dengue Virus | 1 | 2019 | 910 | 0.45 | Why? |
| Nigeria | 6 | 2021 | 2292 | 0.43 | Why? |
| Minority Groups | 2 | 2020 | 1631 | 0.42 | Why? |
| Tuberculosis, Pulmonary | 2 | 2018 | 1171 | 0.42 | Why? |
| State Medicine | 1 | 2020 | 2847 | 0.32 | Why? |
| Dengue | 1 | 2019 | 1565 | 0.32 | Why? |
| Africa | 5 | 2021 | 2986 | 0.31 | Why? |
| Health Status Disparities | 2 | 2020 | 4072 | 0.26 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.23 | Why? |
| Civil Disorders | 1 | 2021 | 60 | 0.21 | Why? |
| Financing, Personal | 1 | 2020 | 113 | 0.20 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.18 | Why? |
| Public-Private Sector Partnerships | 1 | 2021 | 259 | 0.17 | Why? |
| Aspergillus | 1 | 2018 | 347 | 0.15 | Why? |
| Hand Sanitizers | 1 | 2021 | 397 | 0.14 | Why? |
| Aspergillosis | 1 | 2018 | 264 | 0.14 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.14 | Why? |
| Stereotyping | 1 | 2017 | 249 | 0.14 | Why? |
| Critical Illness | 1 | 2018 | 17281 | 0.13 | Why? |
| Health Expenditures | 1 | 2020 | 904 | 0.12 | Why? |
| Public Health Administration | 1 | 2021 | 846 | 0.12 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.11 | Why? |
| Healthcare Disparities | 2 | 2020 | 3893 | 0.11 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.11 | Why? |
| Commerce | 1 | 2020 | 1109 | 0.10 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.10 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.09 | Why? |
| Infection Control | 1 | 2018 | 23131 | 0.09 | Why? |
| Glycated Hemoglobin A | 1 | 2017 | 1316 | 0.09 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.09 | Why? |
| Rural Population | 1 | 2021 | 2408 | 0.09 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.08 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Developing Countries | 2 | 2020 | 4283 | 0.08 | Why? |
| Patient Education as Topic | 1 | 2017 | 1476 | 0.08 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.08 | Why? |
| Chile | 2 | 2021 | 1095 | 0.08 | Why? |
| Humans | 19 | 2021 | 930598 | 0.07 | Why? |
| Health Services Accessibility | 2 | 2021 | 10697 | 0.07 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2017 | 1969 | 0.06 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.05 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.05 | Why? |
| United Kingdom | 1 | 2020 | 18046 | 0.05 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.05 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.05 | Why? |
| Social Control, Formal | 1 | 2021 | 165 | 0.05 | Why? |
| Antibiotics, Antitubercular | 1 | 2017 | 65 | 0.04 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2017 | 15421 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Rifampin | 1 | 2017 | 276 | 0.03 | Why? |
| HIV Infections | 2 | 2017 | 11620 | 0.03 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.03 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.03 | Why? |
| Microscopy | 1 | 2017 | 414 | 0.03 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Animals | 1 | 2019 | 78931 | 0.02 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
| Social Determinants of Health | 1 | 2021 | 1757 | 0.02 | Why? |
| Sputum | 1 | 2017 | 1720 | 0.02 | Why? |
| Self Care | 1 | 2017 | 918 | 0.02 | Why? |
| Laboratories | 1 | 2021 | 2858 | 0.02 | Why? |
| Politics | 1 | 2021 | 1824 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Hyperglycemia | 1 | 2017 | 1363 | 0.02 | Why? |
| Poverty | 1 | 2017 | 2302 | 0.02 | Why? |
| Aged | 2 | 2018 | 215776 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.02 | Why? |
| Male | 3 | 2018 | 367725 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.01 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.01 | Why? |
| Young Adult | 2 | 2017 | 93724 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Adult | 3 | 2017 | 244371 | 0.01 | Why? |
| Middle Aged | 3 | 2017 | 270681 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2021 | 23402 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Female | 3 | 2017 | 380317 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.00 | Why? |
Otu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_